Find Paybotic at the NECANN Illinois Cannabis Convention

WEST PALM BEACH, Fla. (PRWEB)
November 29, 2021

Paybotic is eager to announce that they will be an exhibitor at NECANN in Illinois and will be showcasing their financial solutions that were developed specifically for the marijuana industry. This payment processing software allows dispensaries to provide consumers with a variety of payment options. They also offer their clients custom-tailored financial plans that fit their budgets and unique needs.

NECANN has announced Chicago, Illinois will be hosting the Illinois cannabis convention this December 4th and 5th. The event will take place at the Hilton at 720 South Michigan Ave from 11 am to 5 pm on Saturday, and 10 am to 4 pm on Sunday. Paybotic’s representative, Brian O, Mahlon can be found at booth 1114. This convention is a huge milestone for Illinois’s cannabis industry and the first event that is focused solely on the local market.

NECANN has gathered some of the best exhibitors in the industry together at one of the largest cannabis conventions in the country. There have been several guests announced, including speakers, marketing specialists, and other exhibitors who are passionate about the cannabis industry.

Illinois has made major strides in the fight for legalized cannabis sales and the decriminalization of marijuana. It is estimated by the year 2025 that the state will bring in over 2 billion a year in revenue from cannabis and have expunged over 700,000 marijuana-related police records. This is an incredible achievement.

Many of these dispensaries were a bold investment in what is still considered a high-risk industry. There are still many barriers that exist for these businesses, including financial limitations that result from federal legalities. Fortunately, there are also several agencies that have developed solutions that combat these barriers to help dispensary owners succeed.

NECANN guarantees the event will be the cannabis social experience of the year. Tickets can be purchased on the event webpage or onsite. Onsite box office offers will open at 9 am on both Saturday and Sunday.

About Paybotic

Paybotic is one of the largest payment processing solution providers for high-risk merchants in the United States. The company specializes in helping cannabis-related businesses process customer payments and maintain compliance amid evolving regulation.

As innovators in the FinTech space, products such as the Cashless ATM have been obvious solutions for Paybotic to implement across the cannabis industry. The company actively works with a variety of sizes of businesses—from single store locations to multi-state operators and even publicly-traded companies.

Cannabis business owners or decision makers with interest in one or several of Paybotic’s full suite of industry payment processing services can call 844-420-4729 for more information. Those interested can also visit the Paybotic website to speak with a live agent.

Share article on social media or email:

MIAMI (PRWEB)
November 29, 2021

As the COVID-19 pandemic continues and the world works to adapt and recover to new ways of living, a new Biotech IPO is hoping to bring more interest into an important health sector: mental health. Pasithea Therapeutics, a new and advanced company has partnered with IV Doc to provide in-home ketamine treatments to patients suffering with clinical depression and anxiety. Alongside treatments, Pasithea’s research team is vigorously working to develop alternative therapies to care for psychiatric disorders.

“We’re glad to see a new uptick of investments in the medical sector due to the pandemic, and are hoping to bring it to another area where many people have been struggling: mental health.” said Professor Lawrence Steinman, Executive Co-Founder of the company and a Chairman at the Neurology Department of Stanford University. “As social isolation and economic uncertainty have shaken the world, we’ve seen an increase in the percentage of adults with depression or anxiety, and a strong need to offer new treatments,” he added.

Pasithea Therapeutics has partnered with I.V. Doc® to offer in-home treatments within the US, and Zen Healthcare in the UK to offer services in select clinics. The company has acquired an incredible team of physicians who will travel directly to our patients, and provide IV Ketamine therapy in the comforts of their homes. All patients will be carefully observed by the visiting practitioner throughout their hour of treatment.

By 2027, Pasithea reports the estimated size of the anxiety and depression market to be $19.2 billion; however, estimates could rapidly increase as the pandemic continues. In displaying the financial viability of the space, Pasithea launched a new Biotech IPO on September 15th, and raised $24 million with their initial public offering.

About Pasithea Therapeutics:

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. The biotech operations will focus on developing drugs to target the pathophysiology underlying psychiatric and neurological disorders. Our goal is to cultivate new pharmacological agents displaying significant advantages over conventional therapies.

The company will also be working by providing on-the-ground treatments to help better understand and meet the needs of patients. Through clinics in the United Kingdom and at-home services in the United States, Pasithea will gain deeper knowledge on the effects of Ketamine Infusion Therapy to treat depression. This innovative new practice is still currently being researched within the medical field, but has shown great promise in preliminary studies.

Share article on social media or email:

QWO targets the root cause of cellulite

QWO is a game changer in cellulite treatment and will allow affected women to finally regain their confidence and have their skin looking its best!

NEW YORK (PRWEB)
November 29, 2021

After several successful clinical trials, QWO injectable cellulite treatment is now on the market and offered at Skinly Aesthetics by Dr. Schwarzburg.

“We’re thrilled to be offering QWO here at Skinly,” says Dr. Schwarzburg. “Being one of the first clinics to offer this treatment, I’m excited to finally be able to promise my patients long term results and to successfully put an end to their cellulite.”

The complete and permanent elimination of cellulite with a minimally invasive injectable treatment was never possible until now. Collagenase Clostridium Histolyticum (CCH), the active ingredient in QWO, is an enzyme that breaks down collagen, resulting in the enzymatic disintegration of the fibrous septae and the permanent elimination of cellulite. After years of careful research, development, and testing, QWO injections are now available at Skinly Aesthetics and ready for use on eager patients.

The key ingredient that makes QWO so incredibly effective is Collagenase Clostridium Histolyticum, an enzyme that breaks down Types I and III collagen fibers which make up fibrous septa bands, the root cause of dimpling seen in cellulite.

Manufactured by Endo Aesthetics, QWO was FDA approved on July 6th, 2020, for the treatment of moderate to severe cellulite in the buttocks of adult women.

After multiple successful clinical trials, QWO is clinically proven to permanently eliminate unwanted cellulite in only one to three sessions, which are to be spaced out by three weeks each. Previous cellulite treatments have had mixed results, as they’ve primarily targeted the fat or were surgically invasive with considerable downtime. QWO addresses the true root cause of cellulite dimpling: fibrous septae and remains minimally invasive at the same time. This is where QWO differs from other treatments and why its success rates are so high.

“There has been no effective minimally invasive solution to cellulite until now. I believe QWO will be a game changer and will allow women suffering from this unsightly condition to finally regain their confidence and have their skin looking its best.” – Dr. Schwarzburg, M.D.

About Skinly Aesthetics

Skinly Aesthetics is one of New York’s most successful medical aesthetics clinics, owned and operated by Dr. Schwarzburg, M.D., offering a wide variety of minimally and non-invasive cosmetic procedures. With many years of experience and globally sought-after skill and expertise, Dr. Schwarzburg’s primary goal is to ensure the satisfaction and safety of his patients, which is why he was one of the first physicians to embrace the incredible opportunity of offering this groundbreaking cellulite elimination treatment.

For more information on the QWO treatment, please visit or contact Skinly Aesthetics office directly at (212) 774-4264, or email info@skinlyaesthetics.com.

Share article on social media or email:

Angie Seelal, PA-C

Skin tags are almost always harmless, and do not require treatment. Removal is generally for cosmetic reasons or if they become irritated.

WEST ISLIP, N.Y. (PRWEB)
November 29, 2021

Skin tags are very common. Researchers estimate that about half of all adults will have at least one in their lifetime, with their incidence increasing after age 50. “Skin tags are almost always harmless,” says Angie Seelal of Advanced Dermatology, P.C. “and do not require treatment. Removal is generally for cosmetic reasons or if they become irritated. Your doctor has several options for removing them but removal at home risks bleeding or infection and is not recommended.”

What is a skin tag?

A skin tag, also known as an Acrochordon, is a small benign growth usually attached to the skin by a tiny stalk. It is composed of blood vessels and collagen and enclosed by an outer layer of skin. A skin tag hangs off the skin by its stalk unlike moles and some other skin growths that lie flat against the skin. Most skin tags measure just a couple of millimeters but some may grow as large as 2 centimeters. Skin tags may appear anywhere on the body but are most common where the skin rubs against itself, such as in armpits, groin, neck, eyelids, and under the breasts.

What causes skin tags?

A definitive cause of skin tags isn’t known but because they show up in where the skin folds or wrinkles, it is thought that friction may play a role. Various studies have shown an association between skin tags and the human papillomavirus (HPV) and also a possible link to insulin resistance and high body mass index. Skin tags occur commonly in pregnancy, possibly due to hormonal changes and weight gain. There may be a genetic tendency to develop skin tags.

Who is at risk for skin tags?

Skin tags affect men and women equally. Based on the incidence of their occurrence and research studies, you may be more likely to develop skin tags if you are overweight or obese, have diabetes, are pregnant, or have close family members who have skin tags. “There is no sure-fire way to prevent skin tags,” says Ms. Seelal, “but you might be able to minimize their occurrence by maintaining a healthy weight, getting plenty of exercise, and avoiding clothing or jewelry that repeatedly rub the same area.”

How are skin tags removed?

Dermatologists are the best qualified medical professionals to remove skin tags. They have the training and skills to treat delicate areas, like the eyelid, to minimize scarring, and to diagnose growths that aren’t skin tags. Removal methods include:

•     Heat (cauterization) – burning it off
•     Freezing (cryosurgery) – using a probe containing liquid nitrogen
•     Ligation – cutting off the blood supply to the tag
•     Excision – cutting the tag out with a scalpel

Your doctor will determine the best method based on the size and location of the tag and other factors in your medical profile. Treatment is typically done in the doctor’s office and involves only mild, easily managed discomfort. There is seldom any permanent scarring. Skin tags do not grow back once removed.

“Skin tags shouldn’t be a cause for concern,” says Ms. Seelal. “They pose no threat to your health. You may never notice them and tiny ones might fall off on their own. If they are bothersome, either cosmetically, because they interfere with grooming activities like shaving, or because they are in a location that is prone to irritation, skip the do-it-yourself techniques and talk to a dermatological professional about the best way to remove them.”

Bio: Angie Seelal, PA-C, is a Certified Physician Assistant through the National Commission of Certification of Physician Assistants.

Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York & New Jersey) is one of the leading dermatology centers in the nation, offering highly experienced physicians in the fields of cosmetic and laser dermatology as well as plastic surgery and state-of-the-art medical technologies. http://www.advanceddermatologypc.com.

Share article on social media or email: